|Synonyms:||N-(5-Oxo-D-prolyl)piperidine, NS-105, Fasoracetam|
|Molecular Weight:||196.250 g/mol|
|Appearance:||White crystal powder|
|Storage:||Store in a dry, dark, sealed container at room temperature.|
|Stability:||Stable at least for 2 years when stored probably.|
Fasoracetam is a research chemical of the racetam family. It is a putative compound that failed to show sufficient efficacy in clinical trials for vascular dementia. It is currently being studied for its potential use for attention deficit hyperactivity disorder.
Fasoracetam appears to agonize all three groups of metabotropic glutamate receptors and has improved cognitive function in rodent studies. It is orally bioavailable and is excreted mostly unchanged via the urine.
Fasoracetam was discovered by scientists at the Japanese pharmaceutical company Nippon Shinyaku, which brought it through Phase 3 clinical trials for vascular dementia, and abandoned it due to lack of efficacy.